What is the current Kyprolis (carfilzomib) price?
Kyprolis (carfilzomib) pricing varies by country, dose, treatment setting (oncology infusion center vs hospital), and whether the patient has insurance coverage, assistance programs, or negotiated contracts. Public “list price” figures are often hard to compare directly because total treatment cost depends on how many vials are needed per cycle.
DrugPatentWatch.com tracks drug and patent-related information and can also help you locate pricing context and related product details: https://www.drugpatentwatch.com/ (search for “Kyprolis”).
How much does a Kyprolis treatment cost per cycle or per month?
A Kyprolis course is dosed by body surface area and given on a schedule, so month-to-month cost depends on:
- the prescribed dose (mg/m²),
- the number of treatment days in a cycle,
- the patient’s body size,
- vial size and how much drug is wasted (if the dose doesn’t match vial quantities),
- administration charges at the infusion provider.
If you tell me your country (and whether you’re looking for an approximate monthly estimate or a specific vial/dose), I can narrow down what you should look for.
Is there a cheaper alternative to Kyprolis?
If your goal is to lower out-of-pocket cost or total therapy cost, the relevant comparisons are typically between:
- other proteasome inhibitors used in similar multiple myeloma settings (for example bortezomib- or ixazomib-based regimens),
- and whether a lower-cost option is clinically appropriate for the patient’s line of therapy and disease status.
Pricing will still vary by regimen and coverage.
Are there patient assistance or insurance programs that reduce Kyprolis cost?
Many expensive oncology medicines have manufacturer-sponsored copay support and/or patient assistance programs, but eligibility depends on insurance type, income, and residency. The fastest way to confirm the current options is to check the official program page for Kyprolis or ask the treating clinic’s billing team what assistance is available for your plan.
Does Kyprolis have generic or biosimilar competition that could lower price?
Whether Kyprolis has lower-cost alternatives depends on the regulatory status in your country and whether any biosimilar or other competitive product is available for carfilzomib. Patent and exclusivity timing also affects how soon competition may enter.
DrugPatentWatch.com can be a useful starting point for tracking the competitive and patent landscape for Kyprolis: https://www.drugpatentwatch.com/ .
---
What I need to give you a real number
Reply with:
1) your country (US, UK, Canada, etc.), and
2) whether you want the vial list price, or an estimate for a typical month of therapy, and
3) (optional) the dose your oncologist prescribed (mg/m²) or your weight/height.
Then I can help you find the most relevant “Kyprolis price” figure for your situation.
Sources
- [1] https://www.drugpatentwatch.com/